Lyra Therapeutics, Inc. (LYRA) Operating income 2019–2025
Lyra Therapeutics, Inc. (LYRA) annual operating income history from SEC filings — each fiscal year as reported.
-$31.0MFY2025 · since FY2019: -$16.5M → -$31.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.0M | +67.8% |
| FY2024 | -$96.3M | -43.5% |
| FY2023 | -$67.1M | -19.2% |
| FY2022 | -$56.3M | -29.1% |
| FY2021 | -$43.6M | -96.4% |
| FY2020 | -$22.2M | -34.4% |
| FY2019 | -$16.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice